Canlyniadau Chwilio - T. Uldrick

In vivo analysis of HIV from an occupational exposure to laboratory adapted HIV-IIIB with 20-year follow-up: implications for reservoir formation gan C. Lange, N. Lindo, R. Little, T. Uldrick, S. Hill, J. Bell, K. Lurain, R. Ramaswami, R. Yarchoan, F. Maldarelli

Connect to this object online.

Clones of HIV-infected cells are widely distributed in T cell subsets in blood and in anatomic tissues gan F. Maldarelli, M. Gozoulis, X. Wu, L. Perez, R. Gorelick, C. Lange, S. Hill, J. Virga, T. Uldrick, R. Yarchoan, S. Hughes

Connect to this object online.

OA2-5 LB No evidence of ongoing replication in tissue compartments during combination antiretroviral therapy gan G. Bozzi, S. Watters, F.R. Simonetti, E. Anderson, R. Gorelick, W. Shao, J. Bell, C. Rehm, R. Dewar, R. Yarchoan, T. Uldrick, F. Maldarelli

Connect to this object online.

35 Therapy with the immunomodulatory agent pomalidomide does not lead to changes in HIV-1 viral populations in vivo gan S.A. Watters, M.N. Polizzotto, W. Shao, R. Gorelick, E.M. Anderson, I. Sereti, K. Aleman, L. Kouyoudjian, J.B. Zeldis, T. Uldrick, R. Yarchoan, F. Maldarelli

Connect to this object online.

Interim safety analysis of cancer immunotherapy trials Network - 12 (CITN-12): a Phase 1 study of pembrolizumab in patients with HIV and cancer gan T.S. Uldrick, M.A. 'Mac' Cheever, P.H. Gonçalves, S. Fling, K. Aleman, B. Emu, M.S. Ernstoff, R. Gorelick, J. Kaiser, H. E Kohrt, A. Lacroix, M. Lindsley, L. M Lundgren, K. Lurain, F. Maldarelli, C. Parsons, E. Sharon, A. Widell, R. Yarchoan

Connect to this object online.